Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · Real-Time Price · USD
3.900
-0.060 (-1.52%)
Dec 20, 2024, 4:00 PM EST - Market closed
Qualigen Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | -7.85 | -13.42 | -18.64 | -17.9 | -20.42 | -1.79 | Upgrade
|
| Depreciation & Amortization | 0 | 0 | 0.01 | 0.34 | 0.29 | 0.22 | Upgrade
|
| Other Amortization | 0.74 | 1.47 | - | - | - | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.02 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 1.75 | 0 | Upgrade
|
| Stock-Based Compensation | 0.19 | 1.1 | 4.77 | 5.69 | 2.81 | 0.01 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | -0.25 | -0.01 | 0.05 | Upgrade
|
| Other Operating Activities | 0.49 | 0.62 | 3.91 | -4.83 | 7.9 | 0.02 | Upgrade
|
| Change in Accounts Receivable | - | - | - | 0.04 | 0.55 | 0.13 | Upgrade
|
| Change in Inventory | - | - | - | 0.11 | -0.33 | 0.06 | Upgrade
|
| Change in Accounts Payable | 0.07 | 1.6 | -0.04 | 0.39 | -0.2 | 0.48 | Upgrade
|
| Change in Unearned Revenue | - | - | - | -0.42 | 0.24 | -0.06 | Upgrade
|
| Change in Other Net Operating Assets | 0.47 | -0.49 | -0.6 | 2.09 | -2.34 | 0.91 | Upgrade
|
| Operating Cash Flow | -9.73 | -10.3 | -13.25 | -14.73 | -9.76 | 0.06 | Upgrade
|
| Capital Expenditures | - | - | - | -0.13 | -0.21 | -0.01 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0.01 | -0.1 | -0.19 | Upgrade
|
| Other Investing Activities | -0.66 | 4.22 | -0.18 | - | 0.15 | - | Upgrade
|
| Investing Cash Flow | -0.66 | 4.22 | -0.18 | -0.14 | -0.16 | -0.19 | Upgrade
|
| Short-Term Debt Issued | - | - | 2.9 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 0.33 | Upgrade
|
| Total Debt Issued | 3.48 | - | 2.9 | - | 1.68 | 0.33 | Upgrade
|
| Short-Term Debt Repaid | - | -0.55 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.14 | - | -0.17 | Upgrade
|
| Total Debt Repaid | -2.11 | -0.55 | - | -0.14 | -1.9 | -0.17 | Upgrade
|
| Net Debt Issued (Repaid) | 1.37 | -0.55 | 2.9 | -0.14 | -0.22 | 0.17 | Upgrade
|
| Issuance of Common Stock | 3.47 | - | 0.01 | 9.28 | 31.33 | - | Upgrade
|
| Other Financing Activities | - | - | -0 | -0.71 | -1.36 | - | Upgrade
|
| Financing Cash Flow | 4.83 | -0.55 | 2.91 | 8.43 | 33.76 | 0.17 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | 0.02 | - | - | - | Upgrade
|
| Net Cash Flow | -5.56 | -6.64 | -10.5 | -6.44 | 23.85 | 0.03 | Upgrade
|
| Free Cash Flow | -9.73 | -10.3 | -13.25 | -14.87 | -9.97 | 0.05 | Upgrade
|
| Free Cash Flow Margin | - | - | - | -262.93% | -231.41% | 0.91% | Upgrade
|
| Free Cash Flow Per Share | -50.86 | -101.57 | -172.48 | -253.37 | -344.25 | 4.49 | Upgrade
|
| Cash Interest Paid | 0.06 | - | - | 0 | 0.05 | 0.09 | Upgrade
|
| Cash Income Tax Paid | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -6.57 | -4.27 | -4.1 | -12.83 | - | 0.56 | Upgrade
|
| Unlevered Free Cash Flow | -6.65 | -4.78 | -4.08 | -12.83 | - | 0.72 | Upgrade
|
| Change in Net Working Capital | 2.65 | -1.18 | 0.35 | 4.55 | - | -1.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.